about
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidenceGSTT2 promoter polymorphisms and colorectal cancer riskBenzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 daysProtective Effects of Essential Oils as Natural Antioxidants against Hepatotoxicity Induced by Cyclophosphamide in MiceQuantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostateDietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expressionRedox regulation in cancer: a double-edged sword with therapeutic potential.Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-reviewAdditive regulation of hepatic gene expression by dwarfism and caloric restriction.Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines.Cytochrome P450 humanised mice.A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population.The road map to oral bioavailability: an industrial perspective.Phase I and Phase II enzyme polymorphisms and childhood cancer.Role of genetic changes in the progression of cardiovascular diseases.Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751.Genetic polymorphisms of genes involved in DNA repair and metabolism influence micronucleus frequencies in human peripheral blood lymphocytes.Reproductive toxicants have a threshold of adversity.Pregnane X receptor polymorphisms associated with human diseases.Glutathione S-transferase P1 gene Ile105Val polymorphism might be associated with lung cancer risk in the Chinese Han population.Garlic oil attenuated nitrosodiethylamine-induced hepatocarcinogenesis by modulating the metabolic activation and detoxification enzymes.Erectile Dysfunction Drugs Changed the Protein Expressions and Activities of Drug-Metabolising Enzymes in the Liver of Male Rats.Erectile dysfunction drugs and oxidative stress in the liver of male ratsNovel study on N-nitrosamines as risk factors of cardiovascular diseasesPolymorphisms of GSTT1 and GSTM1 and increased micronucleus frequencies in peripheral blood lymphocytes in residents at an e-waste dismantling site in China.Combination chemoprevention of hamster buccal pouch carcinogenesis by bovine milk lactoferrin and black tea polyphenols.Orientin, a flavanoid, mitigates 1, 2 dimethylhydrazine-induced colorectal lesions in Wistar rats fed a high-fat dietTramadol-induced hepato- and nephrotoxicity in rats: Role of Curcumin and Gallic acid as antioxidants
P2860
Q24618313-1FD60B56-2A1D-40E6-BF2D-3BAB99BE9E91Q24677878-EB37FF6C-D494-44F6-A138-31402DBC9DEFQ28391046-B9FA44B6-273A-4DF5-86F7-7AD69BCB09C4Q28553094-60182D1A-D042-4E48-A45A-0E634A8EFDC9Q28755344-0D6BA2F6-9174-4296-8CD2-08D6B450FFBEQ29615766-CA327453-34E9-435E-A430-3FEA12FA5A19Q33716894-735430B5-3B59-4C20-A98E-E09D296938BAQ33731768-85E641EE-67A2-42C1-B1ED-1D67178D58CEQ34546580-F775AD44-1AB4-4715-BB77-EAC4585CA418Q35619533-48394F6E-52C4-4197-BE9A-A82821ABCB32Q35978586-591B31FC-2558-4E5C-ADE9-06098F14A0BDQ36204229-9044FEDC-AAE2-4C92-A8F0-4781F10425D5Q36213765-DF9FA64B-24D6-44ED-BEC0-A2285120000CQ36543116-33AFE258-EDA2-4D5E-8FFB-98827E9B5266Q36668333-A08468D4-495F-49E0-80BF-3A61A751A10EQ36735715-DB25AE9F-C9E1-44EC-B9D6-7FC30056217CQ37010459-ECFE5D85-D112-4E98-8CE9-E0FE58837E2CQ37382760-F2FAE076-9B50-48BD-9F96-D51DD86F98C9Q37821655-0680A10C-2E75-408B-A848-C29C503D881EQ37879187-BB1B9E27-DA03-4AAE-88FC-7F42A504CF0BQ38138603-D5237EA2-7DDB-4749-B009-7AE0328D9773Q38415164-069A8AF4-755D-4FF2-86C4-8AE52EC88D24Q41160662-5FE6D68B-CA0F-4669-8E42-4253A3FEEB63Q41540824-3CF7CF0B-A050-4F91-98B0-EB5C05CCF49EQ41680225-B8BB3DC4-1204-4310-9A7B-15AED0334B68Q41983614-3944E59C-4BD3-4E84-AEAA-855A1A5D4A6DQ43100251-D72D0A7F-00C6-4EE2-AC72-4B245E39E401Q46764785-F7C88F24-D17F-4363-9764-6FFFFCECA3BFQ57491204-CCF12BBF-A903-4AC7-8B67-511A6D9837B1Q58778835-A13DBE1B-598B-409F-ADC6-FB38AD658BBE
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cancer and phase II drug-metabolizing enzymes.
@ast
Cancer and phase II drug-metabolizing enzymes.
@en
type
label
Cancer and phase II drug-metabolizing enzymes.
@ast
Cancer and phase II drug-metabolizing enzymes.
@en
prefLabel
Cancer and phase II drug-metabolizing enzymes.
@ast
Cancer and phase II drug-metabolizing enzymes.
@en
P356
P1476
Cancer and phase II drug-metabolizing enzymes
@en
P2093
A K Tilmisany
P356
10.2174/1389200033336919
P407
P577
2003-02-01T00:00:00Z